This inventor holds 2 USPTO granted patents. Top assignee: Roussel Uclaf. Active years: 1993-1995.
Location History:
- Swindon Wilts, GB (1993)
- Covingham, GB (1995)
Company Filing History:
Years Active: 1993-1995
Title: Philip T Hambleton: Innovator in Pharmaceutical Chemistry
Introduction
Philip T Hambleton is a notable inventor based in Swindon, Wilts, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on compounds with anti-inflammatory properties. With a total of 2 patents to his name, Hambleton continues to push the boundaries of medicinal chemistry.
Latest Patents
Hambleton's latest patents focus on 3-cycloalkyl-propanamides. These compounds are selected from a group consisting of all tautomeric forms of a cycloalkyl-propanamide. The formula includes various components where R1 is a cycloalkyl of 3 to 6 carbon atoms, and R2 is either hydrogen or an alkyl of 1 to 3 carbon atoms. The compounds also feature R3, R4, R5, R6, and R7, which can be selected from a range of groups including hydrogen, halogen, and various alkyl and alkoxy groups. These compounds are designed to have non-toxic, pharmaceutically acceptable basic salts that exhibit anti-inflammatory activity.
Career Highlights
Philip T Hambleton is currently associated with Roussel Uclaf, a company known for its focus on pharmaceutical innovations. His work has contributed to advancements in the development of new therapeutic agents.
Collaborations
Hambleton has collaborated with notable coworkers such as Charles J Hedgecock and David P Kay. Their combined expertise has further enhanced the research and development efforts in their field.
Conclusion
Philip T Hambleton stands out as an influential inventor in the realm of pharmaceutical chemistry. His innovative patents and collaborations reflect his commitment to advancing medical science.